Evidence map›Paper›PMID 31464101›Full record

SynthesisCancer medicine2019

Parenchymal-sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta-analysis.

Gang Deng, Hui Li, Gui-Qing Jia, Dan Fang, You-Yin Tang, Jie Xie, Ke-Fei Chen, Zhe-Yu Chen

Registry-linked trialAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05705557 (Assessment of Efficacy of ABSOLOK™ Clip System-RFP-2021-01 in Achieving BIliostasis During Parenchymal Transection for Open Liver Resection), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05705557 recruitingnot on this mapstarted 2023, after this paper: background citation

Assessment of Efficacy of ABSOLOK™ Clip System-RFP-2021-01 in Achieving BIliostasis During Parenchymal Transection for Open Liver Resection

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2023 to 2026Enrolled180ConditionsBile LeakArmsABSOLOK™ Clip System
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Ugly: Metastatic Colon Cancer-Surgical Options.Clinics in colon and rectal surgery · 2025
    Review
  12. Segments 4, 7, and 8 liver resection: A case report.Annals of hepato-biliary-pancreatic surgery · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Stage IV Colorectal Cancer Management and Treatment.Journal of clinical medicine · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gang DengDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.ORCID 0000-0002-3363-3512
Hui LiDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.ORCID 0000-0001-7287-2690
Gui-Qing JiaDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.
Dan FangDepartment of Breast Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
You-Yin TangDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.
Jie XieDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.
Ke-Fei ChenDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.
Zhe-Yu ChenDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo assess the safety and efficacy of parenchymal-sparing hepatectomy (PSH) as a treatment of colorectal liver metastases (CLM).

methodsA comprehensive medical literature search was performed. Perioperative and long-term survival outcomes were pooled. Subgroup analysis and meta-regression analysis were performed to identify potential sources of heterogeneity.

resultsA total of 18 studies comprising 7081 CLM patients were eligible for this study. The PSH was performed on 3974 (56.1%) patients. We found that the OS (overall survival; hazard ratio [HR] = 1.01, 95% confidence interval [CI]: 0.94-1.08) and RFS (recurrence-free survival; HR = 1.00, 95% CI: 0.94-1.07) were comparable between non-PSH and PSH group. The perioperative outcomes were better in PSH than in non-PSH group. Non-PSH group was significantly associated with longer operative time (standard mean difference [SMD] = 1.17, 95% CI: 0.33-2.00), increased estimated blood loss (SMD = 1.36, 95% CI: 0.64-2.07), higher intraoperative transfusion rate (risk ratio [RR] = 2.27, 95% CI: 1.60-3.23), and more postoperative complications (RR = 1.39, 95% CI: 1.16-1.66). Meta-regression analyses revealed that no variable influenced the association between surgical types and the survival outcomes.

conclusionsThis study shows that PSH is associated with better perioperative outcomes without compromising oncological outcomes. Given the increasing incidence of hepatic parenchyma, the PSH treatment offers a greater opportunity of repeat resection for intrahepatic recurrent tumors. It should be considered as an effective surgical approach for CLM.

Indexed as

HepatectomyOrgan Sparing TreatmentsColorectal NeoplasmsDisease ManagementFemaleHumansLiver NeoplasmsMalePrognosisProportional Hazards ModelsTreatment Outcomeanatomical hepatectomycolorectal liver metastasismeta-analysisoncological outcomesparenchymal-sparing hepatectomy

Identifiers

PMID31464101
PMCPMC6797569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.